Pictet Asset Management (UK)’s Novavax NVAX Stock Holding History

Pictet Asset Management (UK)’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$122M	Sell	575,680 -55,486	-9%	-$10.2M	0.13%	204
2021 Q1	$114M	Buy	631,166 +193,160	+44%	+$38.5M	0.14%	192
2020 Q4	$48.8M	Buy	438,006 +254,655	+139%	+$27.1M	0.06%	315
2020 Q3	$19.9M	Buy	+183,351	New	+$22.3M	0.03%	429
2018 Q4	–	Sell	-149,434	Closed	-$5.62M	–	1007
2018 Q3	$5.62M	Buy	+149,434	New	+$4.21M	0.01%	706
2016 Q4	–	Sell	-11,964	Closed	-$498K	–	861
2016 Q3	$498K	Buy	11,964 +5,717	+92%	+$738K	﹤0.01%	805
2016 Q2	$761K	Buy	+6,247	New	+$716K	﹤0.01%	803

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pictet Asset Management (UK)'s NVAX Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Novavax (NVAX) stake by 8.8% in Q2 2021, selling an estimated $10.2M and leaving 575,680 shares worth $122M. The position accounts for 0.13% of the portfolio, ranked #204.

Pictet Asset Management (UK) first reported a position in NVAX in Q2 2016 and has held it in 7 quarters since. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

Pictet Asset Management (UK) held 575,680 shares of Novavax worth $122M as of Q2 2021.
Pictet Asset Management (UK) sold 55,486 Novavax shares in Q2 2021, an estimated $10.2M.
Novavax made up 0.13% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #204 holding.
Pictet Asset Management (UK) first reported a position in Novavax in Q2 2016 and has held it in 7 quarters since.
407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.